Home › NDC Lookup › Ingredients › Galphimia Glauca Flowering Top, Luffa Op... › 10237-0472-20
Zicam Cold Remedy Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL Gel, 20 tubes — NDC 10237-0472-20 package photo

Zicam Cold Remedy Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL Gel, 20 tubes

by Church & Dwight Co., Inc. · 20 TUBE, WITH APPLICATOR in 1 CARTON (10237-472-20) / 1.2 mL in 1 TUBE, WITH APPLICATOR
NDC 10237-0472-20
🏷️ FDA NDC (as labeled) 10237-472-20 billing pads the product segment with a zero
This package
Contains20 tubes Pack sizes3 compare ↓
Also comes in: 12 tubes 10237-0472-12 20 tubes 10237-0472-22
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 10237-472-20
Product NDC 10237-472
11-digit billing NDC 10237047220
UNII 93PH5Q8M7E, C4MO6809HU, 6NAF1689IO
SPL Set ID d91738e5-1d2e-41d1-e053-2995a90a7aad
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-02-28
Route NASAL
Dosage form GEL
Substance GALPHIMIA GLAUCA FLOWERING TOP; LUFFA OPERCULATA FRUIT; SCHOENOCAULON OFFICINALE SEED
Why two NDCs? The FDA registers this code as 10237-472-20 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 10237-0472-20. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerChurch & Dwight Co., Inc.
Labeler code10237
First marketedFeb 2022
Product typeHuman Otc Drug
Portfolio156 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Zicam Cold Remedy is a homeopathic nasal gel containing three plant-derived ingredients: Galphimia glauca flowering top, Luffa operculata fruit, and Schoenocaulon officinale seed. In homeopathic tradition, these ingredients are used to address symptoms commonly associated with the common cold. This is an unapproved homeopathic product, meaning it is marketed based on homeopathic principles rather than evaluated by the FDA for effectiveness or safety.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 tubes 20 tubes
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Zicam Cold Remedy 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mLthis 10237-0472-20 Church 20 tubes — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2022
On the market since
Feb 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Zicam Cold Remedy (this brand).

Top reported reactions

Ageusia72
Anosmia59
Dysgeusia18
Parosmia8
Burning Sensation6
Headache5
Nasal Discomfort5

Age at onset

Adult1
Elderly2

Reporter sex

0 reports
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 9 1
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
10237-0472-20 You're viewing this 20 TUBE, WITH APPLICATOR in 1 CARTON (10237-472-20) / 1.2 mL in 1 TUBE, WITH APPLICATOR 2022-02-28 Active
10237-0472-12 12 TUBE, WITH APPLICATOR in 1 CARTON (10237-472-12) / 1.2 mL in 1 TUBE, WITH APPLICATOR 2026-06-01 Active
10237-0472-22 2 CARTON in 1 PACKAGE (10237-472-22) / 20 TUBE, WITH APPLICATOR in 1 CARTON / 1.2 mL in 1 TUBE, WITH APPLICATOR 2026-02-25 Active

Pack size FAQ

What quantity is in NDC 10237-0472-20?
NDC 10237-0472-20 contains 20 tubes — 20 tube, with applicator in 1 carton / 1.2 ml in 1 tube, with applicator.
What is the difference between NDC 10237-0472-20 and NDC 10237-0472-12?
Both are Zicam Cold Remedy Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL Gel — the drug itself is identical. NDC 10237-0472-20 is the 20 tubes package, while NDC 10237-0472-12 is the 12 tubes package.
What NDC number is used to bill for this package of Zicam Cold Remedy Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL Gel?
Bill NDC 10237-0472-20 — the 11-digit billing format is 10237047220. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Zicam Cold Remedy Galphimia Glauca Flowering Top, Luffa Operculata Fruit, and Schoenocaulon Officinale Seed 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL; 4 [hp_X]/1.2mL GEL is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 10237-472-20, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 10237-0472-20, written without dashes as 10237047220. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 10237-0472-20, the first segment (10237) is the labeler code FDA assigned to Church & Dwight Co., Inc.; the middle segment (0472) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (20) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Church & Dwight Co., Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 12 tubes (10237-0472-12), 20 tubes (10237-0472-22). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Church & Dwight Co., Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 35 words ▾

Uses Reduces duration of the common cold and helps relieve nasal congestion Zicam ® Cold Remedy was formulated to shorten the duration of the common cold and may not be effective for flu or allergies.

⏱️ Dosage and Administration 173 words ▾

Directions for best results, use at the first sign of a cold and continue to use until symptoms completely subside adults and children 12 years of age and older: open tube (also see illustration on side of carton) hold tube between thumb and forefinger at the blue band with other hand, hold at handle base, snap open tube and pull out swab apply medication just inside first nostril. Using swirling motion, rotate swab 3 times within nostril. While swirling, gently press outside of first nostril to ensure transfer of medication.

Re-dip swab in tube and mix to re-saturate with medication. Swirl 3 more times in the same nostril while gently pressing outside of nostril. Re-dip swab in tube and mix.

Repeat identical sequence in second nostril. Do not insert swab more than 1/4" past nasal opening. discard swab after use wait at least 30 seconds before blowing nose use 1 tube every 3 hours, not to exceed 5 tubes in one 24 hour period children under 12 years of age: do not use

⚠️ Warnings 159 words ▾

Warnings For nasal use only Do not use if you have a sensitivity or allergy to any of the ingredients. If an allergic reaction occurs, stop use and seek medical help right away. Ask a doctor before use if you have ear, nose, or throat sensitivity susceptibility to nosebleeds When using this product avoid contact with eyes.

Rinse right away with water if it gets in eyes and seek medical help right away. the use of individual swabs by more than one person may spread infection temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur Stop use and ask a doctor if symptoms get worse or last more than 7 days or are accompanied by fever redness or swelling is present new symptoms occur If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 8 words ▾

Other information store at room temperature 15-29°C (59-84°F)

🧪 Active Ingredient 10 words ▾

Active ingredients Galphimia glauca 4x, Luffa operculata 4x, Sabadilla 4x

🧪 Inactive Ingredients 27 words ▾

Inactive ingredients benzalkonium chloride, dibasic sodium phosphate, eucalyptol, eugenol, glycine, hypromellose, menthol, monobasic sodium phosphate, phenethyl alcohol, polysorbate 80, purified water, saccharin sodium, sodium chloride, succinic acid

🎯 Purpose 14 words ▾

Purpose Reduces duration and severity of the common cold and helps relieve nasal congestion

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 10237-0471-15 · Church 10237-0473-25 · Church →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.